![Ugo di Francesco](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ugo di Francesco
Directeur/Membre du Conseil chez
LABOMAR S.P.A.
Profil
Ugo di Francesco is currently Chief Executive Officer at Kedrion SpA since 2023, Chief Executive Officer at Bio Products Laboratory Ltd., Director at Farmindustria SA, Non-Executive Director at Labomar SpA, Director at Chiesi Ltd. since 2012, Director at CHIESI BV, Independent Director at Almirall SA since 2024, Director at Kedrion Holding SpA, and Member of the International Federation of Pharmaceutical Manufacturers.
Former roles include Chief Executive Officer & Vice President at Sigma-Tau Industrie Farmaceutiche Riunite SpA from 2007 to 2011, Chief Executive Officer & Director at CHIESI Farmaceutici SpA, Chief Executive Officer at Novartis Consumer Health SpA, Vice President at Amgen, Inc., Principal at Novartis sro, and Vice President-Pharmaceuticals Division at Bristol-Myers Squibb Srl.
Education includes an MBA from Bologna Business School.
Postes actifs de Ugo di Francesco
| Sociétés | Poste | Début |
|---|---|---|
| LABOMAR S.P.A. | Directeur/Membre du Conseil | - |
| ALMIRALL, S.A. | Directeur/Membre du Conseil | 05/10/2024 |
Chiesi Ltd.
 Chiesi Ltd. Pharmaceuticals: MajorHealth Technology Develops, markets and supplies therapeutic products | Directeur/Membre du Conseil | 06/03/2012 |
Chiesi SA (Belgium)
 Chiesi SA (Belgium) Pharmaceuticals: MajorHealth Technology Engages in research, development and production of medicines for respiratory & neonatology areas | Directeur/Membre du Conseil | - |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology Provides biopharmaceutical research services | Corporate Officer/Principal | - |
Farmindustria SA
 Farmindustria SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Kedrion SpA
 Kedrion SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that produces and distributes blood plasma products | Directeur Général | 01/01/2023 |
KEDRION HOLDING S.P.A.
 KEDRION HOLDING S.P.A. MiscellaneousMiscellaneous Functions as an investment holding company | Directeur/Membre du Conseil | - |
Bio Products Laboratory Ltd.
 Bio Products Laboratory Ltd. Pharmaceuticals: MajorHealth Technology Produces human blood plasma products to treat neurological & immunodeficiency and coagulation diseases | Directeur Général | - |
Anciens postes connus de Ugo di Francesco
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
| ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Ugo di Francesco
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
29
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Almirall SA
 Almirall SA Pharmaceuticals: MajorHealth Technology Engages in the development, manufacture and sale of pharmaceuticals | Health Technology |
Sigma-Tau Industrie Farmaceutiche Riunite SpA
 Sigma-Tau Industrie Farmaceutiche Riunite SpA Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
CHIESI Farmaceutici SpA
 CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Health Technology |
Kedrion SpA
Kedrion SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that produces and distributes blood plasma products | Health Technology |
Farmindustria SA
Farmindustria SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bologna Business School
 Bologna Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Labomar SpA
 Labomar SpA Pharmaceuticals: OtherHealth Technology Engages in research & development and manufacturing of food supplements, medical devices, cosmetics & foods | Health Technology |
Novartis sro
 Novartis sro Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines & provides healthcare and care giving services | Commercial Services |
Chiesi Ltd.
Chiesi Ltd. Pharmaceuticals: MajorHealth Technology Develops, markets and supplies therapeutic products | Health Technology |
Novartis Consumer Health SpA
 Novartis Consumer Health SpA Pharmaceuticals: OtherHealth Technology Manufactures and distributes medical drugs | Health Technology |
Bristol-Myers Squibb SRL
 Bristol-Myers Squibb SRL Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceuticals | Health Technology |
Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. Pharmaceuticals: MajorHealth Technology Produces human blood plasma products to treat neurological & immunodeficiency and coagulation diseases | Health Technology |
Chiesi SA (Belgium)
Chiesi SA (Belgium) Pharmaceuticals: MajorHealth Technology Engages in research, development and production of medicines for respiratory & neonatology areas | Health Technology |
KEDRION HOLDING S.P.A.
KEDRION HOLDING S.P.A. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
